Immuneering Corporation (IMRX), a clinical-stage oncology company, Thursday said it has signed a clinical supply agreement with ...
Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase ...
Almost 20 months after its future was left in limbo by inaction from the Niagara Falls City Council, a bitcoin mining company is back seeking a high-energy use industry operating permit in the city.
Regeneron's Q4 earnings report shows revenue growth, stable EYLEA sales, dividend announcement, and impressive growth for ...
In the Phase II MAIA lung cancer trial, THIO improved patients’ overall survival when taken in combination with Libtayo.
Moments after Regeneron CEO Len Schleifer scolded analysts for asking too many questions about the disappointing sales of eye ...
MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced positive updated data from its THIO-101 ...
With so many places to buy a used car, finding the best one can seem overwhelming. Knowing the pros and cons of each can help. Many, or all, of the products featured on this page are from our ...
Zacks.com on MSN6d
Regeneron to Report Q4 Earnings: Is a Beat in the Cards?Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report fourth-quarter and full-year 2024 results on Feb. 4, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback